Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 -22.72M
March 31, 2026 -19.89M
December 31, 2025 -15.74M
September 30, 2025 -13.89M
June 30, 2025 -12.17M
March 31, 2025 -11.61M
December 31, 2024 -3.746M
September 30, 2024 -19.88M
June 30, 2024 -35.89M
March 31, 2024 -33.62M
December 31, 2023 -28.21M
September 30, 2023 -21.38M
June 30, 2023 -75.56M
March 31, 2023 -16.82M
December 31, 2022 -14.84M
September 30, 2022 -15.63M
June 30, 2022 -14.41M
March 31, 2022 -13.41M
December 31, 2021 -20.00M
September 30, 2021 -12.92M
June 30, 2021 -98.85M
March 31, 2021 -25.99M
December 31, 2020 -11.02M
September 30, 2020 -5.863M
June 30, 2020 -4.349M
Date Value
March 31, 2020 -2.629M
December 31, 2019 -2.595M
September 30, 2019 -6.72M
June 30, 2019 -2.649M
March 31, 2019 -1.068M
December 31, 2018 -3.467M
September 30, 2018 -1.819M
June 30, 2018 -2.301M
March 31, 2018 -14.08M
December 31, 2017 -0.179M
September 30, 2017 -0.968M
June 30, 2017 -3.371M
March 31, 2017 -1.977M
December 31, 2016 -1.96M
September 30, 2016 68.29M
June 30, 2016 -3.205M
March 31, 2016 -1.17M
December 31, 2015 -3.509M
September 30, 2015 -1.482M
June 30, 2015 -3.794M
March 31, 2015 -3.462M
December 31, 2014 -3.549M
September 30, 2014 -2.876M
June 30, 2014 -3.081M
March 31, 2014 -1.494M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Artivion, Inc. -129.41M
Glaukos Corp. -5.306M
TransMedics Group, Inc. -7.092M
Abbott Laboratories -673.00M
AngioDynamics, Inc. -3.148M